Are We Optimizing the Use of Dual Antiplatelet Therapy in Patients Hospitalized with Acute Myocardial Infarction?
Highlights
- • The use of DAPT after discharge increased between 2001 and 2011.
- • Very limited data is available about the trends in the use of DAPT after AMI.
- • Being male and undergoing PCI are positively associated with receiving DAPT.
- • Females, older patients, and CABG patients are not optimally managed with DAPT.
Abstract
Background
Dual antiplatelet therapy (DAPT) is a mainstay treatment for hospital survivors of an acute myocardial infarction (AMI). However, there are limited data on the prescribing patterns of DAPT among patients hospitalized with AMI during recent years.